Literature DB >> 8023658

Somatosensory evoked potentials during isoflurane anaesthesia.

T Porkkala1, V Jäntti, S Kaukinen, V Häkkinen.   

Abstract

Short latency somatosensory evoked potentials (SEPs) to median nerve stimulation during isoflurane anaesthesia were recorded in 12 elective-surgery patients. The effect of isoflurane on the shape, amplitude and latency of SEPs was evaluated. SEPs were recorded at awake, 1 MAC, 1.5 MAC, at electroencephalogram (EEG) burst suppression and at continuous suppression levels. Finally, SEPs were recorded when anaesthesia was lightened back to 1 MAC. The peak latency and amplitude of the first cortical N20 wave were measured. The latencies increased with increasing isoflurane concentrations. At high concentrations only an almost monophasic N20 wave was recorded, reduced in shape and amplitude. No specific changes could be correlated with the burst suppression or suppression patterns. This suggests that EEG and SEP generators are differently affected with increasing isoflurane concentration. The results indicate that SEPs can also be recorded in drug-induced EEG suppression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8023658     DOI: 10.1111/j.1399-6576.1994.tb03874.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  3 in total

1.  Effects of isoflurane on somatosensory-evoked potentials in calves: a pilot study.

Authors:  Geoffrey Truchetti; Patrick Burns; Sylvain Nichols; Joane Parent
Journal:  Can J Vet Res       Date:  2015-01       Impact factor: 1.310

2.  Brain function monitoring during off-pump cardiac surgery: a case report.

Authors:  Paolo Zanatta; Enrico Bosco; Piero Di Pasquale; Agarwal Nivedita; Carlo Valfrè; Carlo Sorbara
Journal:  Cases J       Date:  2008-08-15

3.  Clonidine does not attenuate median nerve somatosensory evoked potentials during isoflurane anesthesia.

Authors:  T Porkkala; V Jäntti; V Häkkinen; S Kaukinen
Journal:  J Clin Monit Comput       Date:  1998-04       Impact factor: 2.502

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.